BREIL GL10 Instrukcja Użytkownika Pobierz pdf (Strona 84)

I C 07 D 403/12 Z C 07 D 217/22

A 01 077 945

I C 07 D 403/14 Z C 07 D 403/10

A 00 867 435

I C 07 D 403/14 Z C 07 D 209/14

A 01 109 785

I C 07 D 405/04 Z C 07 D 319/18

A 00 906 912

I C 07 D 405/04 Z C 07 D 309/38

A 01 115 716

I C 07 D 405/06 Z C 07 F 009/60

A 00 885 232

I C 07 D 405/06 Z C 07 D 213/06

A 00 974 584

I C 07 D 405/06 Z C 07 D 209/14

A 01 109 785

I C 07 D 405/12 Z A 61 K 038/55

A 00 771 565

I C 07 D 405/12 Z C 07 D 311/94

A 00 787 723

I C 07 D 405/12 Z C 09 K 019/34

A 00 821 719

I C07D405/12

A 00 845 461

B 97118049.2

C 17.10.1997 Q En

H 03.06.1998 R En

E 15.01.2003

F 29.11.1996 IT BO960612

K Verfahren zur Herstellung von der

I-Form von Terazosin wasserfreien

Mono-Salzsäure

O Alfa Chemicals Italiana S.r.l.

Via Tiraboschi, 48

24122 Bergamo (IT)

N Cannata, Vincenzo

12, Via Annibale Clo’, 40044 Borgo

Nuovo di

Pontecchio Marconi, Bologna (IT)

Ferrario, Tiziano

18, Via Gianetti

20020 Ceriano Laghetto (Milano) (IT)

Galbiati, Barbara

2, Via Goldoni

20129 Milano (IT)

I C 07 D 405/12 Z C 07 D 249/14

A 01 044 970

I C 07 D 405/14 Z A 61 K 031/435

A 00 659 078

I C 07 D 405/14 Z C 07 D 401/04

A 00 892 795

I C 07 D 405/14 Z C 07 D 319/18

A 00 906 912

I C 07 D 405/14 Z C 07 D 401/04

A 01 169 317

I C 07 D 407/12 Z C 07 D 305/14

A 00 534 709

I C 07 D 409/04 Z C 07 D 319/18

A 00 906 912

I C 07 D 409/04 Z C 07 D 309/38

A 01 115 716

I C 07 D 409/06 Z C 07 D 241/08

A 00 907 643

I C 07 D 409/06 Z C 07 D 213/06

A 00 974 584

I C 07 D 409/06 Z C 07 D 209/14

A 01 109 785

I C 07 D 409/12 Z C 07 D 213/65

A 00 649 412

I C 07 D 409/12 Z C 07 D 403/12

A 00 729 468

I C 07 D 409/12 Z C 07 D 239/42

A 00 925 286

I C 07 D 409/12 Z C 07 D 249/14

A 01 044 970

I C 07 D 409/14 Z C 07 D 403/12

A 00 729 468

I C 07 D 409/14 Z C 07 D 239/42

A 00 925 286

I C 07 D 413/04 Z C 07 D 261/12

A 00 934 286

I C 07 D 413/04 Z C 07 D 311/74

A 00 937 057

I C 07 D 413/04 Z C 07 D 307/87

A 01 123 284

I C 07 D 413/04 Z C 07 D 401/04

A 01 169 317

I C 07 D 413/06 Z C 07 D 401/06

A 00 820 451

I C 07 D 413/06 Z C 07 D 273/04

A 00 891 341

I C 07 D 413/10 Z C 09 K 019/34

A 00 821 719

I C 07 D 413/12 Z C 07 D 403/12

A 00 729 468

I C 07 D 413/12 Z C 07 D 311/94

A 00 787 723

I C 07 D 413/12 Z C 07 D 213/30

A 00 889 033

I C 07 D 413/12 Z C 07 D 239/42

A 00 925 286

I C 07 D 413/12 Z C 07 D 277/24

A 01 090 914

I C 07 D 417/04 Z C 07 D 261/12

A 00 934 286

I C 07 D 417/04 Z A 61 K 031/445

A 01 119 355

I C 07 D 417/04 Z C 07 D 307/87

A 01 123 284

I C 07 D 417/06 Z C 07 D 213/69

A 00 984 934

I C 07 D 417/12 Z C 07 D 213/65

A 00 649 412

I C 07 D 417/12 Z C 07 D 277/34

A 00 801 063

I C 07 D 417/12 Z C 07 D 213/30

A 00 889 033

I C 07 D 417/12 Z C 07 D 277/46

A 00 934 938

I C 07 D 417/12 Z C 07 D 277/24

A 01 090 914

I C 07 D 417/14 Z C 07 D 311/94

A 00 787 723

I C07D451/02, A 61 K 031/46

A 00 604 354

B 93610065.0

C 20.12.1993 Q En

H 29.06.1994 R En

E 15.01.2003

F 23.12.1992 DK 154192

16.07.1993 US 93182

K Antidepressiv und gegen die

Parkinsonsche Krankheit wirkende

Verbindungen

O NEUROSEARCH A/S

Pederstrupvej 93

2750 Ballerup (DK)

N Moldt, Peter

Langebjergvej 355

DK-3050 Humlebaek (DK)

Scheel-Krüger, Jorgen

Ejbydalsvej 127

DK-2600 Glostrup (DK)

Jensen, Leif Helth

Puggaardsgade 6, 4.th.

DK-1573 Copenhagen V (DK)

I C07D457/04

A 01 196 415

B 00949572.2

C 29.06.2000 Q Fr

H 17.04.2002 R Fr

E 08.01.2003

F 02.07.1999 FR 9908538

K PROCEDE DE PREPARATION DE

L’ACIDE LYSERGIQUE

O Aventis Pharma S.A.

20, avenue Raymond Aron

92160 Antony (FR)

N GAULLIER, Jean-Claude

23 Rue du Vert Pré

F-93460 Gournay Sur Marne (FR)

Q PCT/FR 20/00001 (Fr)

R WO 20/01002 () 11.1.2001

I C 07 D 471/04 Z C 07 D 215/08

A 00 620 216

I C07D471/04

A 00 912 564

B 96936832.3

C 22.10.1996 Q En

H 06.05.1999 R En

E 08.01.2003

F 21.06.1996 US 669895

K VERFAHREN ZUR HERSTELLUNG

VON TETRAHYDROIMIDAZOCHINO-

LINAMINEN

O MINNESOTA MINING AND

MANUFACTURING COMPANY

3M Center, P.O. Box 33427

St. Paul, Minnesota 55133-3427 (US)

N LINDSTROM, Kyle, J.

P.O. Box 33427

Saint Paul, MN 55133-3427 (US)

Q PCT/US 19/96016 (En)

R WO 19/97048 () 24.12.1997

I C07D471/04, A 61 K 031/505,

C07D213/30, C 07 C 211/45

A 00 912 572

B 97933661.7

C 11.07.1997 Q En

H 06.05.1999 R En

E 15.01.2003

F 13.07.1996 GB 9614756

07.12.1996 GB 9625495

K BICYCLISCHE HETEROAROMATISCHE

VERBINDUNGEN ALS PROTEIN

TYROSINE KINASE INHIBITOREN

O GLAXO GROUP LIMITED

Glaxo Wellcome House Berkeley

Avenue

Greenford, Middlesex UB6 ONN

(GB)

N COCKERILL, George Stuart, Glaxo

Wellcome plc

Gunnelle Wood Road

Stevenage, Hertfordshire SG1 2NY

(GB)

CARTER, Malcolm Clive, Glaxo

Wellcome plc

Gunnells Wood Road

Stevenage, Hertfordshire SG1 2NY

(GB)

GUNTRIP, Stephen Barry, Glaxo

Wellcome plc

+pat+ 1 15.1.2003

1 2 ... 79 80 81 82 83 84 85 86 87 88 89 ... 185 186

Komentarze do niniejszej Instrukcji

Brak uwag

BREIL GL10 Instrukcja Użytkownika Strona 84

Komentarze do niniejszej Instrukcji